Dr Reddy’s turns to single-use for biosimilar production in India
Dr Reddy’s will expand its biosimilar manufacturing capacity in Hyderabad by 4,000L using GE Healthcare’s FlexFactory platform based on single-use technologies.
Dr Reddy’s will expand its biosimilar manufacturing capacity in Hyderabad by 4,000L using GE Healthcare’s FlexFactory platform based on single-use technologies.
Therachon AG has contracted Catalent Biologics to manufacture a candidate protein therapeutic for a rare form of dwarfism.
Sartorius Stedim Biotech (SSB) has announced it will combine technologies with US-based cell culture analysers Nova Biomedical, as a result of increased customer demand.
Novartis will add around 350 Swiss jobs to support its innovative biologics pipeline as it looks to cut 500 more “traditional” development and manufacturing roles.